-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 EDvxP94tYzP9fy9CBRC10zZacY1aT7nLOuGbvKVT0vK4AVA8HeqEjXvanluptjbs
 agrC1Nve7BHri/IkIIAzvw==

<SEC-DOCUMENT>0001104659-04-041611.txt : 20041230
<SEC-HEADER>0001104659-04-041611.hdr.sgml : 20041230
<ACCEPTANCE-DATETIME>20041230140239
ACCESSION NUMBER:		0001104659-04-041611
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20041230
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20041230
DATE AS OF CHANGE:		20041230

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYANOTECH CORP
		CENTRAL INDEX KEY:			0000768408
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				911206026
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-14602
		FILM NUMBER:		041233542

	BUSINESS ADDRESS:	
		STREET 1:		73-4460 QUEEN KAAHUMANU HWY
		STREET 2:		SUITE 102
		CITY:			KAILUA KONA
		STATE:			HI
		ZIP:			96740
		BUSINESS PHONE:		8083261353

	MAIL ADDRESS:	
		STREET 1:		73-4460 QUEEN KAAHUMANU HWY
		STREET 2:		SUITE 102
		CITY:			KAILUA-KONA
		STATE:			HI
		ZIP:			96740
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a04-15442_18k.htm
<DESCRIPTION>8-K
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div>

<div style="border:none;border-top:double windowtext 9.0pt;padding:0in 0in 0in 0in;">

<p align="center" style="border:none;margin:0in 0in .0001pt;padding:0in;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE
COMMISSION</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">Form 8-K</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Current
Report Pursuant to Section 13 or 15(d)</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">of the
Securities Exchange Act of 1934</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">December 30, 2004</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of report (Date of
earliest event reported)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">Cyanotech Corporation</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant
as specified in its charter)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.7%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">NEVADA</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.44%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.7%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">000-14602</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.44%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.7%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">91-1206026</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.7%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other
  jurisdiction of incorporation)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.44%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.7%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File
  Number)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.44%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.7%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(IRS Employer
  Identification Number)</font></p>
  </td>
 </tr>
</table>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">73-4460 Queen Kaahumanu Highway,
Suite #102, Kailua Kona, HI 96740</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal
executive offices)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(808) 326 &#150; 1353</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone
number)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Not Applicable</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Former name or former
address, if changed since last report)</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></p><p style="margin:0in 0in .0001pt 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="font-size:10.0pt;margin:0in 0in .0001pt 24.0pt;text-indent:-12.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160; </font><font face="Times New Roman">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p><p style="margin:0in 0in .0001pt 24.0pt;text-indent:-12.0pt;"><font size="2" face="Times New Roman" 
style="font-size:10.0pt;">&nbsp;</font></p><p style="font-size:10.0pt;margin:0in 0in .0001pt 24.0pt;text-indent:-12.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160; </font><font face="Times New Roman">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p><p style="margin:0in 0in .0001pt 24.0pt;text-indent:-12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="font-size:10.0pt;margin:0in 0in .0001pt 24.0pt;text-indent:-12.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160; </font><font face="Times New Roman">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p><p style="margin:0in 0in .0001pt 24.0pt;text-indent:-12.0pt;"><font size="2" face="Times New Roman" s
tyle="font-size:10.0pt;">&nbsp;</font></p><p style="font-size:10.0pt;margin:0in 0in .0001pt 24.0pt;text-indent:-12.0pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" face="Times New Roman" style="font-size:3.0pt;">&#160;&#160;&#160; </font><font face="Times New Roman">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>

<div style="border:none;border-bottom:double windowtext 9.0pt;padding:0in 0in 0in 0in;"><p style="border:none;margin:0in 0in .0001pt;padding:0in;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p></div>

<p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></p></div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\byang\04-15442-1\task265275\15442-1-ba.htm',USER='byang',CD='Dec 29 23:11 2004' -->


<br clear="all" style="page-break-before:always;">


<div><p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ITEM 7.01. Regulation FD Disclosure</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following information is being furnished, not filed, pursuant to Item 7.01. Attached hereto as Exhibit 99.1 and incorporated by reference herein is the press release announcing the departure of Dr. John E. Dore, the Company&#146;s Scientific Director. Such press release contains certain forward-looking statements. The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent th
at such information is superceded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On December 30, 2004 Cyanotech Corporation issued a press release announcing the departure of Scientific Director, John E. Dore Ph.D., effective December 31, 2004. Dr. Dore is leaving his position to pursue other opportunities in research but will maintain a month-to-month consulting relationship with Cyanotech Corporation which is expected to last through the first six months of calendar 2005.</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</f
ont></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ITEM 9.01. FINANCIAL STATEMENTS, PROFORMA FINANCIAL INFORMATION AND EXHIBITS.</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c) Exhibits.</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1 Press release dated December 30, 2004 announcing the departure of Dr. John E. Dore, the Company&#146;s Scientific Director.</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p 
style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Signatures</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CYANOTECH CORPORATION (Registrant)</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-
size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="58%" valign="top" style="padding:0in .7pt 0in .7pt;width:58.9%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">December 30, 2004</font></p></td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.22%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p></td>
  <td width="36%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:36.88%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Jeffrey H. Sakamoto</font></p></td>
 </tr>
 <tr>
  <td width="58%" valign="top" style="padding:0in .7pt 0in .7pt;width:58.9%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
  <td width="41%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:41.1%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jeffrey H. Sakamoto</font></p></td>
 </tr>
 <tr>
  <td width="58%" valign="top" style="padding:0in .7pt 0in .7pt;width:58.9%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
  <td width="41%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:41.1%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President &#150; Finance &amp; Administration</font></p></td>
 </tr>
 <tr>
  <td width="58%" valign="top" style="padding:0in .7pt 0in .7pt;width:58.9%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p></td>
  <td width="41%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:41.1%;"><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Principal Financial and Accounting Officer)</font></p></td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p><p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p><p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></p><p style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p></div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\byang\04-15442-1\task265275\15442-1-ba.htm',USER='byang',CD='Dec 29 23:11 2004' -->


</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a04-15442_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>

<head>





</head>

<body lang="EN-US" link="blue" vlink="purple">

<div>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.1</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="323" height="71" src="g154421kaimage002.jpg"></font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FOR
IMMEDIATE RELEASE</font></u></b></p>

<p style="line-height:normal;margin:0in 0in 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="17%" valign="top" style="padding:0in .7pt 0in .7pt;width:17.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contacts:</font></p>
  </td>
  <td width="42%" valign="top" style="padding:0in .7pt 0in .7pt;width:42.1%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Corporation:</font></p>
  </td>
  <td width="40%" valign="top" style="padding:0in .7pt 0in .7pt;width:40.04%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investors and Media:</font></p>
  </td>
 </tr>
 <tr>
  <td width="17%" valign="top" style="padding:0in .7pt 0in .7pt;width:17.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="42%" valign="top" style="padding:0in .7pt 0in .7pt;width:42.1%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cyanotech Corporation</font></p>
  </td>
  <td width="40%" valign="top" style="padding:0in .7pt 0in .7pt;width:40.04%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Guerrant Associates</font></p>
  </td>
 </tr>
 <tr>
  <td width="17%" valign="top" style="padding:0in .7pt 0in .7pt;width:17.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="42%" valign="top" style="padding:0in .7pt 0in .7pt;width:42.1%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jeffrey H. Sakamoto</font></p>
  </td>
  <td width="40%" valign="top" style="padding:0in .7pt 0in .7pt;width:40.04%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laura Guerrant</font></p>
  </td>
 </tr>
 <tr>
  <td width="17%" valign="top" style="padding:0in .7pt 0in .7pt;width:17.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="42%" valign="top" style="padding:0in .7pt 0in .7pt;width:42.1%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(808) 326-1353</font></p>
  </td>
  <td width="40%" valign="top" style="padding:0in .7pt 0in .7pt;width:40.04%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(808) 882-1467</font></p>
  </td>
 </tr>
 <tr>
  <td width="17%" valign="top" style="padding:0in .7pt 0in .7pt;width:17.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="42%" valign="top" style="padding:0in .7pt 0in .7pt;width:42.1%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">jsakamoto@cyanotech.com</font></p>
  </td>
  <td width="40%" valign="top" style="padding:0in .7pt 0in .7pt;width:40.04%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">lguerrant@guerrantir.com</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="line-height:normal;margin:0in 0in 6.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CYANOTECH CORPORATION ANNOUNCES DEPARTURE</font></b></p>

<p align="center" style="line-height:normal;margin:0in 0in 6.0pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OF SCIENTIFIC DIRECTOR</font></b></p>

<p style="line-height:normal;margin:0in 0in 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">KAILUA KONA, Hawaii.&#151;December&nbsp;30, 2004 &#151;
Cyanotech Corporation (Nasdaq: CYAN), a world leader in producing high-value
natural products from microalgae, today announced the departure of its Scientific
Director, John E. Dore, Ph.D., effective December&nbsp;31, 2004.&#160; Dr. Dore is leaving his position to pursue
other opportunities in research, but will maintain a month-to-month consulting
relationship with the Company during the course of the next six months.</font></p>

<p style="line-height:normal;margin:0in 0in 6.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About Cyanotech</font></b></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cyanotech Corporation, a
world leader in microalgal technology, produces high-value natural products
from microalgae and is the world&#146;s largest commercial producer of natural
astaxanthin (pronounced &#147;asta-zan-thin&#148;) from microalgae. &#160;Products include BioAstin&#174; natural
astaxanthin, a powerful antioxidant with expanding applications as a human
nutraceutical; NatuRose&#174; natural astaxanthin for the aquaculture and animal
feed industries; Spirulina Pacifica&#174;, a nutrient-rich dietary supplement; and
phycobiliproteins, which are fluorescent pigments used in the immunological
diagnostics market.&#160; Spirulina Pacifica
and BioAstin are sold directly online through the Company&#146;s website,
www.nutrex-hawaii.com, as well as through resellers in over 30 countries
worldwide.&#160; Technical information for the
Company&#146;s phycobiliproteins products is available at www.phycobiliprotein.com.
Corporate data and other product information are available at
www.cyanotech.com.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<h3 align="left" style="margin:12.0pt 0in 3.0pt;page-break-after:avoid;text-align:left;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;Safe
Harbor&#148; Statement under the Private Securities Litigation Reform Act of 1995 </font></u></b></h3>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Except
for statements of historical fact, the statements in this press release are
forward-looking.&#160; Such statements are
subject to a number of risks and uncertainties that could cause actual results
to differ materially from the statements made.&#160;
These factors include, but are not limited to, general economic
conditions, forecasts of sales in future periods, changes in sales levels to
our largest customers, weather patterns, risks associated with the acceptance
of new products, competition, foreign exchange fluctuations, government
regulation, and other factors more fully detailed in the Company&#146;s recent Form
10-Q and annual form 10-K filings with the Securities and Exchange Commission.</font></p>

<p style="line-height:normal;margin:0in -9.35pt .0001pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">#
# #</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\byang\04-15442-1\task265317\15442-1-ka.htm',USER='byang',CD='Dec 29 23:29 2004' -->


</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g154421kaimage002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g154421kaimage002.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#__@`<4V]F='=A<F4Z($UI8W)O<V]F="!/
M9F9I8V7_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-#AT5%A$8(Q\E)"(?(B$F
M*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_P``+"`!'`4,!`1$`_\0`
M'``!``$%`0$```````````````8"`P0%!P@!_\0`-Q```0,#`P($!`,(`@,`
M`````0(#!``%$082(3%!$Q1180<B4J$R<8$5%B,V0G21LH+!DK'P_]T`!``H
M_]H`"`$!```_`.>TI2OH!5G:"<#)P,X%?,T!!Z&E*NQHLB;(1'BL./O.'"&V
MTE2E'V%26R_#N^WI$S:A$1V(0E3,G*5*41D#IQQWK%.B;T--+OY:;$1&24E?
MS[0<%6/3/O6%84+;U):PM"D$RFB-R2,C<*]*4I2E*4I2E*4I2E*4I2E*4I7_
MT.RUY8H3CK6\A:0O$_3[U]9:;$%G)4I2\*('XB!W`_ZJ22K7HO2MUM$I4W]L
M,+"C)9"DN`?+\J\#MG^D_P#54P?B!:+)=[R];+$#$G!`9;.$`$`@Y'9)SG`K
M$1K&S?N7'L;MDW/(>2IU:=H2H!>XD'KDCC]:W+\G0VLM1P(R&OV;';967'-J
M6/%5QM1GIQR<_I6J5\.UW1=UFV*<PNVPW5(94XLJ+NU(*@"..,XSWJ-3=/7B
MW6UFXS+>\Q%?QL<7C!R,C/ID>M3*)#M.D--VW5UJN29-Q("5L.+!0YNX6@)'
M*2/7VJ/7;7=\N5TDSF)*X`DMI;6U'60"D=.?7D\^]8D35=YB06;=YQ;D!IQ*
M_++P4JPK=M)ZXSVKHJ&9OQ)D6S4$9B/`8ML@)V.+*G'2%)4KD#``[?F:Z52E
M*4I2E*4I2E*4I2E*4I2O_]'LM*\L5/-*6!6GFV-5:@MJ'[4MO*<86IK=C:LH
M[CMZC-:"]ZD=E3+@Q:77H=HE.E0AI5M0>G.WMDC.*T0`'04I0C/6LJ/<I\2*
M]%C37V6'QAUMMPI2O\Q4^L%YU/K1R&R[`BS+?:G$./HX1XQ`(3G/!/?'`XYJ
MIQW1FJ=37!Z](-G$5L-(94H-*<4"=RE8XR.!C_W6B<T&ZYI9>H84]MYA3I2R
MP4'>M/B;$\_4>.*TUYTW=[`ZRU<X:F5OIW-@*"]V.HX[CTJ]IBY3XUYA0V)C
M[4=Z8UXK*%D)7\PZBO1M*4I2E*4I2E*4I2E*4I2E?__2[+2E<!T%I)&J[NXB
M2M:(<9(6\4<%1)X2#VSS_BI!\384C3ULM]JB71]5L=R!$=4%%.W&/FZE//0]
M,5S:E*4I72=+19NG=`S-36Z],I6ZDE<9;06C*20`3G(5S]QUKG3[SDF0X^\L
MK==45K4>Y)R35;$V5&+99D.H#3@=0D*.T+'(..F:E5M^)%R;U$S=[NTBX>"P
MIE#:0&]F2"5)XZ\<^U2*P7;1EZD.W.ZQVV;S)FI+;0SN2<@(V8X]R?7.:ZI2
ME*4I2E*4I2E*4I2E*4K_T^RTI2N2_"6^VBUP[A&G2VHK[C@<!=5M"D`8Z].#
MG_-1[XCZB8U#J7=#=\6)%;#32QT4>JB/UX_2HG2E*5F6J(N==(["(KTH*<!6
MTPDJ6I`/S8`]LU*?B)+TTZ8,?3[`8<:"A)0AI303TVA22!\PYJ%4I6QT]_,E
ML_NVO]A7I:E*4I2E*4I2E*4I2E*4K__4[+2E*5QSX87!V)`NK473[MS?("BM
M&P#&#A"BH_F<#-<^=SXJ]R-AW'*,8V\]*HI2E*GWPRM5^0[)OMI:B.H;26"U
M(64ET\*(20#@].3ZU$]0W9Z^7V5<I#267'E\MIY"<#&,]^E:VE*V.GOYDMG]
MVU_L*]+4I2E*4I2E*4I2E*4I2O_5[+2E*4KAOPRDWE=X?M=KN#4-$AOQ'5N-
M!PC;T*0>_-1_4UI79-13+>Y)$E32\ET<;LC/(['GFM52E*5/GGK98?A_'DV'
M4#S5RE;?,L-OYW$CY@4?TX]>*@-9EKM,^]3D0K=&7(>5V2.$CU)Z`>YJ2(^&
M]VC7N#!N[C42-+44B4A86D$`G;V^8XXS6XM]AT5IV]W6!J":W,\)M"F"YD<$
M$D83_6.*L6"YZ.3:8<-J`HW=<Y&QQ;>5#^*"E6_T"<#%=FI2E*4I2E*4I2E*
M4I2O_];LM*4I2E>7X<A468R^EQUO8L$J:44K`[X(]JFVLX%IO-O8N^E+6^ME
MH*,V0EM02.GXL\E0YR1GW-0*E*5O]&V&X7N]M*@Q&9*8:TO/)?5M00#^$GGK
MBLKX@WMN\W_:FU)M[L,%ET925+4#SDC@@=JCT*#+N,I,6%&<D/K_``MMIR37
M:M`_LFPZ8\&2IF!/:),]+Z@AQ*L\9SVQC':H3\1]=1]1^':[:%&&PYO4\H8\
M50X&/;D_G4#K8Z>_F2V?W;7^PKTJ2`"2<`=36CMUTN=\BJG6],:/#4I0CE]*
MEJ=`.-Q`(V@D<=3BKAN\N%=X<.YLL-M3&?D>;4=H?3RI!SV(R0?8T5>I(LTB
MXHBA96HI@L@X4]GA&?3<>?RKXY?E.:3%[A,!]:FDK0P3C*B0"C/8YR/SK[^\
M34G3CUU@IW+:!"F7?E4VL'!0H=015:[K(E7IZUVY#8,1"527W02E!5RE(2,9
M..>O'%65W6XQ[J+2^B-YB2TIR'(`4&U[<;DJ3G((!SP>:HMMRO4R?-9=3`2W
M!?#3I2%Y7\@5D<\?BQ^E+)>;A.M+-WG*A,Q%L%Y:&PK>@`9ZDX^U5P9]ZNUN
M3<8K<2,T^G?'9D)4I2DGH5$$;<CG`!QFK\2ZO.WV9;I"&FTQF&7`H*Y4I>[(
MY[#;54.Z.2K]<+?L1X41MI25I.2HK"L@_EBK<R[OF](LUN:;7)#/CO.ND[&4
M9P.!R23G`XZ51-NLVRQ'7[@EB3N6AJ*B."A3KBC@)()('..<],U]G2KW;[<N
M>MN))\%!<=CMA25;1R=JB>3CU`S[5:-\DS;G&CVPQO`D0/.)=>"CD;@`,`CL
M:QD:GFR+7;)#49A#TV<8BBHE2!C<-Z<8R#MX_.JEZJ<@+N;$^.AUZ$ME#?EB
M</J=_`C!_"K/7VYK-ER;Y"MZYJFX;ZFDEQR,V%))2.2$K)Y./4#/M7__U^CB
M^R)]PA,VSR_@2X)F)=>2H\92`,`CZJRK%=U72TF9(;0R6W'&UJ2K*%;%$%22
M?Z3C-8]KODJ\QIJ8[#<:7'>`2A_)!;5A2%G'/*3_`)JS!N]YDIN#KK<$-P'7
M6EI0%[EE*<@CGCDBOK&HI$QBTL1H[9GW"*)*PHGPV$8&5'N>3@#O5^7=)MHF
MQ$7!++T26Z&`^TDH4TX?P[DDG(/3(/%4V_4B)%\E6F6R8[J'5"*L_AD)3C.#
M]0[C]:UL[5MRC3Y##4*.M#3BD)4I2LD`XKA7EW?H^XJ:Z,O][<CMZ0C^7:CS
M5*1YA:=RVDJ!*L#.#WQGUK5ZSTB-*W9J&Q)5*;<9#@4M(21R1C[5'O+N_1]Q
M3R[OT?<4\N[]'W%=+T18W[=HR;J2%<WHTTMN?)M2IO",X!21S^?;-<X?\W+D
M.29!4X\ZHK6M2AE1/)-=!LM@?TGI9K6L*8'9A:!5&=1_#4A2@-N1SGH<U";W
M<)^H+L]<YJ$>,\1D(P`D`8`'/I6!Y=WZ/N*>7=^C[BMCI]AT:CMI*.!+:[CZ
MA7I!Q`<;4A710(-1FR2'=,6QJRW".M9CY1'=:*2'D9.TX)!!YP0?\UE:JA/7
M;2SC(B;GU*:6EI2DY00L$\YQD#/>LB7!5<;JTVX'&HD-O>A33FPJ<5D#H<@)
M3G_R]JU";7-MS-UM<=E3D1;S4F*I3@)&Y8+B3DYX(*O^57M1Z?DJ=<N-F4EM
MY_:B:PKA$A`(^;V6D=#W'%7O"=L-_N%P6T7(-Q#:EK01N9<2-O()Y!&.G0BJ
MFX[MYU##NQ;+4.`TX&-Q&YU:\`G`Z)`'?DDU<L\61'GWUQYO:F1+WM'<#N3X
M:1^G(/6M1I^V138&[/(M:HTQV&MAZ0$MG&00>0K)K/M5SD6JW1K5<83AFQVT
MM)\%22EX`8"@21C('0XQ5;%I$G55QESH#2VEQF$M%P)7@C=N'W%7+3;3!U+=
MW6XJ&(SS;`;V!("B`K=P.G45:F1I%IU.N^MLE^))C)8DI2H!;1224J`)&1R0
M1UKY=4/ZCMJ'+>RI#D.2W)CEY0"7EH.2G@D@8XR?6JYMU>N<!^!`BK3.>;+9
M2Z4A+.1@J403G'MG-:R3H]$B9%MR@L1HUI##4D*&Y#B5C!QGGIG'0]*O2(UQ
MNL"T1YT!"'HEP2)*6UI""E*5#>G!Z'(XZCTK/O6GD/V81[6RRP\Q(;E-)QM2
MM:%`X4??IFO_T.D2KN]/A/0H4-8N#K91X;JDA+1(P2H@G('MG-:I_1R'I$"U
MK"C$C6I3"9(4`I#H4@A0&?8GT[5GMBYSK*U:IL1+#RG?+R5LK2$%H#)6G!R-
MP&,=1N]JJ-J=M6I8D^$'7F9*#&EAQ[<4@<MJ&X]CD<?57VV0I3,*_I<:PJ1,
M?6T-P^9)2`#UXZ=ZP8-MFVH66[>7\0L6U,.8R%IW('"@I)S@X(((ST/%9<Y*
MM4/06HZ"B%&DHD/O+(!44<I0D9SR<9)[#O5PV)%U@38TU*F5F:X]'>0H;VCG
CY5I(Z'_XUI6K5<MJC<V6URRXLN+:("5_,<*`)XR,''O7_]D_
`
end

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
